HUSA, Petr, Marián OLTMAN, Ljubomir IVANOVSKI, Vratislav ŘEHÁK, Mehmed GRIBAJCEVIC, Diethelm MESSINGER, Andreas TIETZ and Petr URBÁNEK. The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe. In Hepatitis C 3rd International Conference The third decade ad beyond. 2009.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe.
Name in Czech Úspěšnost peginterferonu alfa-2a (40kD) u pacientů v minulosti léčených infikovaných HCV genotypem 1: výsledky otevřeného programu rozšířeného přístupu ve východní Evropě.
Authors HUSA, Petr, Marián OLTMAN, Ljubomir IVANOVSKI, Vratislav ŘEHÁK, Mehmed GRIBAJCEVIC, Diethelm MESSINGER, Andreas TIETZ and Petr URBÁNEK.
Edition Hepatitis C 3rd International Conference The third decade ad beyond. 2009.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30300 3.3 Health sciences
Country of publisher Ireland
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Tags International impact
Changed by Changed by: prof. MUDr. Petr Husa, CSc., učo 945. Changed: 8/7/2009 10:52.
PrintDisplayed: 5/9/2024 02:50